title: Things are not as bad as they seem: physicians' ability to predict their clinical practice when a new vaccine becomes available.
abstract: Survey results regarding primary care physicians' likelihood of recommending a new vaccine were compared before and after the vaccine was licensed by the Food and Drug Administration for three new vaccines: herpes zoster (HZ), human papillomavirus (HPV) and rotavirus (RV), using physician networks representative of United States physicians. The main purpose of this study was to determine (a) how accurately physicians predict their eventual vaccine recommendations and the barriers they will experience in delivering the new vaccine and (b) whether physicians shift towards more or less strongly recommending a new vaccine from pre- to post-licensure. Responses from 284, 152 and 184 physicians were analyzed for the three vaccines, respectively. For all vaccines, there was a significant association between physicians' pre- and post-licensure recommendations (p<0.05). When responses changed from pre- to post-licensure, physicians tended to recommend a given vaccine more strongly than they had anticipated pre-licensure. Before vaccine availability, physicians tended to predict greater barriers to vaccine delivery than they eventually experienced. Surveys are useful for predicting physician practices, but may provide a slightly pessimistic view of physician adoption of new vaccines. Such data can be helpful in devising strategies to encourage vaccine delivery by physicians.
authors: Children's Outcomes Research Program, Children's Hospital Colorado, Aurora, CO.
authors: Laura
authors: L
authors: Seewald
authors: Laura
authors: L
authors: Hurley
authors: Lori A
authors: LA
authors: Crane
authors: Fran
authors: F
authors: Dong
authors: Shannon
authors: S
authors: Stokley
authors: Matthew F
authors: MF
authors: Daley
authors: Jennifer
authors: J
authors: Barrow
authors: Christine
authors: C
authors: Babbel
authors: L Miriam
authors: LM
authors: Dickinson
authors: Allison
authors: A
authors: Kempe
mesh_terms: D000293:Adolescent; D002648:Child; D003625:Data Collection; D005260:Female; D053061:Herpes Zoster Vaccine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D053918:Papillomavirus Vaccines / Q000627:therapeutic use; D058007:Physicians, Primary Care / Q000706:statistics & numerical data*; D022243:Rotavirus Vaccines / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology; D014612:Vaccines / Q000627:therapeutic use*
chemical_list: D053061:Herpes Zoster Vaccine; D053918:Papillomavirus Vaccines; D022243:Rotavirus Vaccines; D014612:Vaccines
references: MMWR Recomm Rep. 2007 Mar 23;56(RR-2):1-24
references: 17380109
references: MMWR Recomm Rep. 2006 Aug 11;55(RR-12):1-13
references: 16902398
references: MMWR Recomm Rep. 2008 Jun 6;57(RR-5):1-30; quiz CE2-4
references: 18528318
references: Health Psychol. 1996 Sep;15(5):398-402
references: 8891719
references: Pediatrics. 2009 Nov;124(5):e809-16
references: 19822592
references: Pediatrics. 2006 Dec;118(6):2280-9
references: 17142510
references: Eval Health Prof. 2008 Mar;31(1):43-64
references: 18184632
references: MMWR Morb Mortal Wkly Rep. 2010 May 7;59(17):521-4
references: 20448529
references: Ann Intern Med. 2010 May 4;152(9):555-60
references: 20439573
references: J Infect Dis. 2008 Mar 1;197 Suppl 2:S216-23
references: 18419400
references: Virtual Mentor. 2012 Jan 01;14(1):39-49
references: 23116916
references: Am J Manag Care. 2004 Jun;10(6):383-91
references: 15209482
references: Health Mark Q. 2007;24(1-2):77-91
references: 19042521
references: Pediatrics. 2010 Sep;126(3):425-33
references: 20679306
references: MMWR Morb Mortal Wkly Rep. 2009 Sep 18;58(36):997-1001
references: 19763075
references: Pediatrics. 2007 Jan;119(1):1-10
references: 17200265